3/17
08:13 am
inkt
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs [Yahoo! Finance]
Medium
Report
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs [Yahoo! Finance]
3/17
07:30 am
inkt
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs
Medium
Report
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs
3/10
05:52 am
inkt
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers [Yahoo! Finance]
High
Report
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers [Yahoo! Finance]
3/10
05:30 am
inkt
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
High
Report
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
3/10
05:29 am
inkt
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology [Yahoo! Finance]
High
Report
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology [Yahoo! Finance]
3/10
05:00 am
inkt
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology
High
Report
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology
2/3
11:28 pm
inkt
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia [Yahoo! Finance]
Medium
Report
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia [Yahoo! Finance]
2/3
09:30 pm
inkt
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
Medium
Report
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
1/19
01:06 am
inkt
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at
Wall Street
Low
Report
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at
Wall Street
1/11
01:03 am
inkt
MiNK Therapeutics (NASDAQ:INKT) was downgraded by analysts at
Wall Stree
Medium
Report
MiNK Therapeutics (NASDAQ:INKT) was downgraded by analysts at
Wall Stree
1/8
12:00 pm
inkt
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
Low
Report
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
1/3
01:08 am
inkt
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at
Wall Street
Medium
Report
MiNK Therapeutics (NASDAQ:INKT) was upgraded by analysts at
Wall Street